
Tirzepatide is a once-weekly injectable, dual glucagon-like peptide 1 (GLP-1) receptor and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist. It works by increasing insulin production and lowering glucagon secretion. This helps to regulate blood sugar and digestion rate, which controls appetite & food cravings. A small change in the molecule allows the drug to last weeks in our bodies rather than the natural version our bodies make, which only lasts minutes.
- Increase insulin production
- Reduces food intake by lowering appetite
- Slows food digestion in the stomach
- Weight loss
- Improved cardiometabolic measures
- A1C Production